Integrated single-cell RNA sequencing and two-sample Mendelian randomization reveal CD4 + T cell-expressed COMT and JUN as shared candidate genes for Alzheimer's disease and type 2 diabetes mellitus
Background Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are high-burden diseases; T2DM independently elevates AD risk via shared pathogenesis, yet their shared peripheral immune pathways and genetically supported cell-specific targets remain undefined. Objective To identify shared immune subsets, key genes and candidate compounds for AD and T2DM via integrated scRNA-seq and two-sample Mendelian randomization. Methods We constructed an integrated multi-omics framework combining peripheral blood mononuclear cell (PBMC) single-cell RNA sequencing (scRNA-seq) and two-sample Mendelian randomization (2SMR) using 10 public GEO datasets, with core analyses covering cell annotation, cell-cell communication profiling, differential expression analysis, eQTL-based 2SMR, in silico gene function prediction, and molecular docking with dynamics simulation for compound screening. Results CD4 + T cells were inferred as the most abundant adaptive immune subset and a potential intercellular communication hub in peripheral blood of both AD and T2DM. Dual scRNA-seq/2SMR screening identified consistently upregulated shared candidate genes COMT and JUN , validated at single-cell and bulk transcriptome levels; myricetin and tauroursodeoxycholic acid were screened as candidate compounds with high predicted binding affinity to the encoded proteins. The 100 ns molecular dynamics simulation confirmed favorable structural stability of the COMT -myricetin complex (RMSD ∼1.2 Å). Conclusions As an exploratory bioinformatics investigation, this study proposes a testable hypothesis that CD4 + T cells and the COMT / JUN axis may act as a potential shared immune regulatory node in the concurrent pathogenesis of AD and T2DM, differing from the canonical T cell-driven pathological process in classic autoimmune diseases. All findings remain preliminary and require dedicated experimental validation.
Authors
- C.-Y. Ou (ORCID: https://orcid.org/0009-0003-2347-1614)
- 于海东
- Huajun Long (ORCID: https://orcid.org/0000-0002-7489-3943)
- Jun Deng
- Binbin Chen
Institutions
- Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine) (CN)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1177/13872877261506457
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00